Finance

Hemodialysis concentrate maker reports revenues, updates trials

Published in Blood Weekly, June 5th, 2003

Rockwell Medical Technologies, Inc., (RMTI), a hemodialysis concentrate manufacturer, reported that its first quarter 2003 sales were $3,435,000, an increase of 40.5% over the first quarter of 2002.

First quarter loss per share narrowed to $.01, a $.04 per share improvement over the first quarter of 2002. The company generated a positive EBITDA in the first quarter.

First quarter sales growth of 40.5% was due to a combination of strong growth in the company's core concentrate product lines and to the expansion of ancillary product sales. The company realized substantial growth from its Dri-Sate Dry Acid Concentrate product line with sales up 45% from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-06-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry